The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Viberzi: Newly Approved for Irritable Bowel Syndrome

by Roni Shye on June 10, 2015 at 9:56 am

Viberzi (eluxadoline) was approved by the FDA on May 27, 2015 as a new option for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

What is irritable bowel syndrome?

Irritable bowel syndrome or IBS is a disorder that affects the large intestine. IBS can be diarrhea- or constipation-predominant, meaning you mostly experience either one or the other. Symptoms can include stomach pain, cramping, bloating, gas, diarrhea, and constipation.

It’s not known exactly what causes IBS, but factors like young age, female gender, genetics, or mental health problems may put a person at greater risk.

When will Viberzi be available?

According to the manufacturer, Actavis, the Viberzi launch is anticipated for the first quarter of 2016.

How is Viberzi taken?
Viberzi will be available as a tablet in 75 mg and 100 mg strengths. The recommended dosage of Viberzi in adults is 100 mg twice daily taken with food.

How does Viberzi work?
Viberzi works by activating receptors in the nervous system to lessen the amount of bowel contractions a patient with IBS-D may experience.

What is unique about Viberzi?
Viberzi is the first medication of its kind in a new class of drugs called mu-opioid receptor agonists, used for irritable bowel syndrome with diarrhea (IBS-D).

Will this medication be a controlled substance?

Since Viberzi affects the opioid receptors of the brain, the FDA has recommended that it be classified as a controlled substance. However, the scheduling designation for Viberzi is under review at the moment, and it will be determined before the release in 2016.

What are the side effects associated with Viberzi?

The most common side effects include stomach pain, constipation, and nausea.

Want more information?

See the press announcement from the FDA regarding Viberzi here.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.